HEADER TRANSCRIPTION/INHIBITOR 28-JUL-22 7YMK TITLE ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN C381S C417S Y537S MUTANT TITLE 2 IN COMPLEX WITH AN COVALENT SELECTIVE ESTROGEN RECEPTOR DEGRADER 29C TITLE 3 AND GRIP PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: ESTROGEN RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ER,ER-ALPHA,ESTRADIOL RECEPTOR,NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 5 GROUP A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 OTHER_DETAILS: AMINO ACIDS 295 TO 304(AGAGAGAGAG) IN THE SAMPLE COMPND 9 SEQUENCE ARE A LINKER THAT WE DESIGNED, AND SER 381/417/537 IS A COMPND 10 DRUG-RESISTANT MUTATION PRODUCED BY THE WILD-TYPE PROTEIN.; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: GRIP PEPTIDE; COMPND 13 CHAIN: C, D; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ESR1, ESR, NR3A1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_TAXID: 9606 KEYWDS COMPLEX, INHIBITOR, ESTROGEN RECEPTOR ALPHA, TRANSCRIPTION-INHIBITOR KEYWDS 2 COMPLEX, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR J.MIN,H.B.HU,Y.YANG,C.E.DONG,H.B.ZHOU,C.-C.CHEN,R.-T.GUO REVDAT 3 20-DEC-23 7YMK 1 JRNL REVDAT 2 29-NOV-23 7YMK 1 REMARK REVDAT 1 31-MAY-23 7YMK 0 JRNL AUTH Y.WANG,J.MIN,X.DENG,T.FENG,H.HU,X.GUO,Y.CHENG,B.XIE,Y.YANG, JRNL AUTH 2 C.C.CHEN,R.T.GUO,C.DONG,H.B.ZHOU JRNL TITL DISCOVERY OF NOVEL COVALENT SELECTIVE ESTROGEN RECEPTOR JRNL TITL 2 DEGRADERS AGAINST ENDOCRINE-RESISTANT BREAST CANCER. JRNL REF ACTA PHARM SIN B V. 13 4963 2023 JRNL REFN ISSN 2211-3835 JRNL PMID 38045063 JRNL DOI 10.1016/J.APSB.2023.05.005 REMARK 2 REMARK 2 RESOLUTION. 2.25 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.25 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 33.78 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 24031 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1268 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.31 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1731 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2800 REMARK 3 BIN FREE R VALUE SET COUNT : 105 REMARK 3 BIN FREE R VALUE : 0.3160 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3750 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 55 REMARK 3 SOLVENT ATOMS : 153 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 44.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.63000 REMARK 3 B22 (A**2) : 3.57000 REMARK 3 B33 (A**2) : -2.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.310 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.235 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.199 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.489 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3882 ; 0.009 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 3756 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5248 ; 1.580 ; 1.637 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8690 ; 1.324 ; 1.581 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 469 ; 6.320 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 184 ;36.960 ;22.174 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 724 ;16.558 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 23 ;20.142 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 500 ; 0.078 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4178 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 763 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 7YMK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 29-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1300031241. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : LIQUID ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER METALJET REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.34138 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : BRUKER PHOTON III REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25394 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.250 REMARK 200 RESOLUTION RANGE LOW (A) : 33.780 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 10.11 REMARK 200 R MERGE (I) : 0.08730 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2700 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.25 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 6.48 REMARK 200 R MERGE FOR SHELL (I) : 0.51070 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.240 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 5DI7 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.36 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 18% (W/V) PEG 3350, 0.25 M AMMONIUM REMARK 280 SULFATE, AND 0.1 M HEPES PH 7.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 295.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 97.90350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 97.90350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 26.24050 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 50.74000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 26.24050 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 50.74000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 97.90350 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 26.24050 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 50.74000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 97.90350 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 26.24050 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 50.74000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1330 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11490 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -6.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 920 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 11420 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 295 REMARK 465 GLY A 296 REMARK 465 ALA A 297 REMARK 465 GLY A 298 REMARK 465 ALA A 299 REMARK 465 PHE A 461 REMARK 465 LEU A 462 REMARK 465 SER A 463 REMARK 465 SER A 464 REMARK 465 THR A 465 REMARK 465 LEU A 466 REMARK 465 LYS A 467 REMARK 465 SER A 468 REMARK 465 LEU A 469 REMARK 465 GLU A 470 REMARK 465 GLU A 471 REMARK 465 LYS A 472 REMARK 465 LEU A 549 REMARK 465 HIS A 550 REMARK 465 ALA A 551 REMARK 465 PRO A 552 REMARK 465 THR A 553 REMARK 465 SER A 554 REMARK 465 ALA B 295 REMARK 465 GLY B 296 REMARK 465 ALA B 297 REMARK 465 GLY B 298 REMARK 465 ALA B 299 REMARK 465 GLY B 300 REMARK 465 ALA B 301 REMARK 465 GLY B 302 REMARK 465 ALA B 303 REMARK 465 LEU B 462 REMARK 465 SER B 463 REMARK 465 TYR B 526 REMARK 465 SER B 527 REMARK 465 MET B 528 REMARK 465 LYS B 529 REMARK 465 CYS B 530 REMARK 465 LYS B 531 REMARK 465 ASN B 532 REMARK 465 VAL B 533 REMARK 465 VAL B 534 REMARK 465 PRO B 535 REMARK 465 LEU B 536 REMARK 465 SER B 537 REMARK 465 ASP B 538 REMARK 465 LEU B 539 REMARK 465 LEU B 540 REMARK 465 LEU B 541 REMARK 465 GLU B 542 REMARK 465 MET B 543 REMARK 465 LEU B 544 REMARK 465 ASP B 545 REMARK 465 ALA B 546 REMARK 465 HIS B 547 REMARK 465 ARG B 548 REMARK 465 LEU B 549 REMARK 465 HIS B 550 REMARK 465 ALA B 551 REMARK 465 PRO B 552 REMARK 465 THR B 553 REMARK 465 SER B 554 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 303 117.17 -39.51 REMARK 500 SER B 338 155.13 179.23 REMARK 500 LEU B 408 80.45 -156.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 788 DISTANCE = 7.84 ANGSTROMS DBREF 7YMK A 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 7YMK C 601 608 PDB 7YMK 7YMK 601 608 DBREF 7YMK B 305 554 UNP P03372 ESR1_HUMAN 305 554 DBREF 7YMK D 601 608 PDB 7YMK 7YMK 601 608 SEQADV 7YMK ALA A 295 UNP P03372 LINKER SEQADV 7YMK GLY A 296 UNP P03372 LINKER SEQADV 7YMK ALA A 297 UNP P03372 LINKER SEQADV 7YMK GLY A 298 UNP P03372 LINKER SEQADV 7YMK ALA A 299 UNP P03372 LINKER SEQADV 7YMK GLY A 300 UNP P03372 LINKER SEQADV 7YMK ALA A 301 UNP P03372 LINKER SEQADV 7YMK GLY A 302 UNP P03372 LINKER SEQADV 7YMK ALA A 303 UNP P03372 LINKER SEQADV 7YMK GLY A 304 UNP P03372 LINKER SEQADV 7YMK SER A 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7YMK SER A 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7YMK SER A 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQADV 7YMK ALA B 295 UNP P03372 LINKER SEQADV 7YMK GLY B 296 UNP P03372 LINKER SEQADV 7YMK ALA B 297 UNP P03372 LINKER SEQADV 7YMK GLY B 298 UNP P03372 LINKER SEQADV 7YMK ALA B 299 UNP P03372 LINKER SEQADV 7YMK GLY B 300 UNP P03372 LINKER SEQADV 7YMK ALA B 301 UNP P03372 LINKER SEQADV 7YMK GLY B 302 UNP P03372 LINKER SEQADV 7YMK ALA B 303 UNP P03372 LINKER SEQADV 7YMK GLY B 304 UNP P03372 LINKER SEQADV 7YMK SER B 381 UNP P03372 CYS 381 ENGINEERED MUTATION SEQADV 7YMK SER B 417 UNP P03372 CYS 417 ENGINEERED MUTATION SEQADV 7YMK SER B 537 UNP P03372 TYR 537 ENGINEERED MUTATION SEQRES 1 A 260 ALA GLY ALA GLY ALA GLY ALA GLY ALA GLY SER LEU ALA SEQRES 2 A 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 A 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 A 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 A 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 A 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 A 260 HIS ASP GLN VAL HIS LEU LEU GLU SER ALA TRP LEU GLU SEQRES 8 A 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 A 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 A 260 ARG ASN GLN GLY LYS SER VAL GLU GLY MET VAL GLU ILE SEQRES 11 A 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 A 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 A 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 A 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 A 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 A 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 A 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 A 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 A 260 LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 A 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 C 8 ALA ILE LEU HIS ARG LEU LEU GLN SEQRES 1 B 260 ALA GLY ALA GLY ALA GLY ALA GLY ALA GLY SER LEU ALA SEQRES 2 B 260 LEU SER LEU THR ALA ASP GLN MET VAL SER ALA LEU LEU SEQRES 3 B 260 ASP ALA GLU PRO PRO ILE LEU TYR SER GLU TYR ASP PRO SEQRES 4 B 260 THR ARG PRO PHE SER GLU ALA SER MET MET GLY LEU LEU SEQRES 5 B 260 THR ASN LEU ALA ASP ARG GLU LEU VAL HIS MET ILE ASN SEQRES 6 B 260 TRP ALA LYS ARG VAL PRO GLY PHE VAL ASP LEU THR LEU SEQRES 7 B 260 HIS ASP GLN VAL HIS LEU LEU GLU SER ALA TRP LEU GLU SEQRES 8 B 260 ILE LEU MET ILE GLY LEU VAL TRP ARG SER MET GLU HIS SEQRES 9 B 260 PRO GLY LYS LEU LEU PHE ALA PRO ASN LEU LEU LEU ASP SEQRES 10 B 260 ARG ASN GLN GLY LYS SER VAL GLU GLY MET VAL GLU ILE SEQRES 11 B 260 PHE ASP MET LEU LEU ALA THR SER SER ARG PHE ARG MET SEQRES 12 B 260 MET ASN LEU GLN GLY GLU GLU PHE VAL CYS LEU LYS SER SEQRES 13 B 260 ILE ILE LEU LEU ASN SER GLY VAL TYR THR PHE LEU SER SEQRES 14 B 260 SER THR LEU LYS SER LEU GLU GLU LYS ASP HIS ILE HIS SEQRES 15 B 260 ARG VAL LEU ASP LYS ILE THR ASP THR LEU ILE HIS LEU SEQRES 16 B 260 MET ALA LYS ALA GLY LEU THR LEU GLN GLN GLN HIS GLN SEQRES 17 B 260 ARG LEU ALA GLN LEU LEU LEU ILE LEU SER HIS ILE ARG SEQRES 18 B 260 HIS MET SER ASN LYS GLY MET GLU HIS LEU TYR SER MET SEQRES 19 B 260 LYS CYS LYS ASN VAL VAL PRO LEU SER ASP LEU LEU LEU SEQRES 20 B 260 GLU MET LEU ASP ALA HIS ARG LEU HIS ALA PRO THR SER SEQRES 1 D 8 ALA ILE LEU HIS ARG LEU LEU GLN HET PEG A 601 7 HET IX0 B 601 43 HET SO4 B 602 5 HETNAM PEG DI(HYDROXYETHYL)ETHER HETNAM IX0 N-(4-((1S,4S,6R)-3-(4-HYDROXYPHENYL)-6-(N-(4- HETNAM 2 IX0 HYDROXYPHENYL)-N-(2,2,2-TRIFLUOROETHYL)SULFAMOYL)-7- HETNAM 3 IX0 OXABICYCLO[2.2.1]HEPT-2-EN-2-YL)PHENYL)-3-METHYLBUT-2- HETNAM 4 IX0 ENAMIDE HETNAM SO4 SULFATE ION FORMUL 5 PEG C4 H10 O3 FORMUL 6 IX0 C31 H29 F3 N2 O6 S FORMUL 7 SO4 O4 S 2- FORMUL 8 HOH *153(H2 O) HELIX 1 AA1 LEU A 306 LEU A 310 5 5 HELIX 2 AA2 THR A 311 ALA A 322 1 12 HELIX 3 AA3 SER A 338 LYS A 362 1 25 HELIX 4 AA4 GLY A 366 LEU A 370 5 5 HELIX 5 AA5 THR A 371 SER A 395 1 25 HELIX 6 AA6 ASN A 413 VAL A 418 5 6 HELIX 7 AA7 GLY A 420 MET A 438 1 19 HELIX 8 AA8 GLN A 441 GLY A 457 1 17 HELIX 9 AA9 HIS A 474 ALA A 493 1 20 HELIX 10 AB1 THR A 496 ASN A 532 1 37 HELIX 11 AB2 SER A 537 ARG A 548 1 12 HELIX 12 AB3 ILE C 602 GLN C 608 1 7 HELIX 13 AB4 SER B 305 LEU B 310 5 6 HELIX 14 AB5 THR B 311 GLU B 323 1 13 HELIX 15 AB6 SER B 338 LYS B 362 1 25 HELIX 16 AB7 THR B 371 SER B 395 1 25 HELIX 17 AB8 ASN B 413 VAL B 418 5 6 HELIX 18 AB9 GLY B 420 MET B 438 1 19 HELIX 19 AC1 GLN B 441 SER B 456 1 16 HELIX 20 AC2 THR B 465 ALA B 493 1 29 HELIX 21 AC3 THR B 496 LEU B 525 1 30 HELIX 22 AC4 ILE D 602 GLN D 608 1 7 SHEET 1 AA1 2 LYS A 401 ALA A 405 0 SHEET 2 AA1 2 LEU A 408 ASP A 411 -1 O LEU A 410 N LEU A 402 SHEET 1 AA2 2 LYS B 401 ALA B 405 0 SHEET 2 AA2 2 LEU B 408 ASP B 411 -1 O LEU B 410 N LEU B 402 CISPEP 1 ARG A 335 PRO A 336 0 2.57 CRYST1 52.481 101.480 195.807 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019055 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009854 0.000000 0.00000 SCALE3 0.000000 0.000000 0.005107 0.00000